139 related articles for article (PubMed ID: 21531292)
1. Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives.
Bigott-Hennkens HM; Dannoon SF; Noll SM; Ruthengael VC; Jurisson SS; Lewis MR
Nucl Med Biol; 2011 May; 38(4):549-55. PubMed ID: 21531292
[TBL] [Abstract][Full Text] [Related]
2. Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re,
Wang J; Makris G; Kuchuk M; Radford L; Gallazzi F; Lewis MR; Jurisson SS; Hennkens HM
Nucl Med Biol; 2021; 94-95():46-52. PubMed ID: 33515899
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Characterization, and In Vitro Evaluation of New (99m)Tc/Re(V)-Cyclized Octreotide Analogues: An Experimental and Computational Approach.
Li Y; Ma L; Gaddam V; Gallazzi F; Hennkens HM; Harmata M; Lewis MR; Deakyne CA; Jurisson SS
Inorg Chem; 2016 Feb; 55(3):1124-33. PubMed ID: 26789775
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
Behera A; Banerjee I; De K; Munda RN; Chattopadhayay S; Samanta A; Sarkar B; Ganguly S; Misra M
Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
[TBL] [Abstract][Full Text] [Related]
5. In vitro structure-activity relationship of Re-cyclized octreotide analogues.
Dannoon SF; Bigott-Hennkens HM; Ma L; Gallazzi F; Lewis MR; Jurisson SS
Nucl Med Biol; 2010 Jul; 37(5):527-37. PubMed ID: 20610157
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a
Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM
Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006
[TBL] [Abstract][Full Text] [Related]
7. Melanoma targeting with [
Carta D; Salvarese N; Morellato N; Gao F; Sihver W; Pietzsch HJ; Biondi B; Ruzza P; Refosco F; Carpanese D; Rosato A; Bolzati C
Nucl Med Biol; 2016 Dec; 43(12):788-801. PubMed ID: 27694057
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of Re/
Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
[TBL] [Abstract][Full Text] [Related]
9. [99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results.
Maina T; Nock B; Nikolopoulou A; Sotiriou P; Loudos G; Maintas D; Cordopatis P; Chiotellis E
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):742-53. PubMed ID: 12029547
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor targeting with hydrophilic [
Makris G; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Nucl Med Biol; 2019 Apr; 71():39-46. PubMed ID: 31129499
[TBL] [Abstract][Full Text] [Related]
11. NOTA and NODAGA [
Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
[TBL] [Abstract][Full Text] [Related]
12. Tetraamine-modified octreotide and octreotate: labeling with 99mTc and preclinical comparison in AR4-2J cells and AR4-2J tumor-bearing mice.
Nikolopoulou A; Maina T; Sotiriou P; Cordopatis P; Nock BA
J Pept Sci; 2006 Feb; 12(2):124-31. PubMed ID: 16059963
[TBL] [Abstract][Full Text] [Related]
13. Novel 99mTc '4 + 1' peptide conjugates: tuning the biodistribution by variation of coligands.
Kunstler JU; Seidel G; Bergmann R; Gniazdowska E; Walther M; Schiller E; Decristoforo C; Stephan H; Haubner R; Steinbach J; Pietzsch HJ
Eur J Med Chem; 2010 Sep; 45(9):3645-55. PubMed ID: 20570022
[TBL] [Abstract][Full Text] [Related]
14. p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the
H A Kankanamalage P; Hoerres R; Ho KV; Anderson CJ; Gallazzi F; Hennkens HM
Nucl Med Biol; 2022; 108-109():1-9. PubMed ID: 35144046
[TBL] [Abstract][Full Text] [Related]
15. Coordination-Mediated Synthesis of Purification-Free Bivalent
Taira Y; Uehara T; Tsuchiya M; Takemori H; Mizuno Y; Takahashi S; Suzuki H; Hanaoka H; Akizawa H; Arano Y
Bioconjug Chem; 2018 Feb; 29(2):459-466. PubMed ID: 29320158
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
[TBL] [Abstract][Full Text] [Related]
17. [(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.
Maina T; Nock BA; Cordopatis P; Bernard BF; Breeman WA; van Gameren A; van den Berg R; Reubi JC; Krenning EP; de Jong M
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):831-40. PubMed ID: 16568203
[TBL] [Abstract][Full Text] [Related]
18. Detection of sites of infection in mice using 99mTc-labeled PN(2)S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study.
Meléndez-Alafort L; Nadali A; Pasut G; Zangoni E; De Caro R; Cariolato L; Giron MC; Castagliuolo I; Veronese FM; Mazzi U
Nucl Med Biol; 2009 Jan; 36(1):57-64. PubMed ID: 19181269
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.
De K; Banerjee I; Misra M
Amino Acids; 2015 Jun; 47(6):1135-53. PubMed ID: 25743164
[TBL] [Abstract][Full Text] [Related]
20. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
